
Common Dreams op-ed: Why Walgreens’ New CEO Should Alarm Us
Why Walgreens’ New CEO Should Alarm Us The man who oversaw massive store closures and job cuts at Staples is now in charge of one of America’s most important companies. The following op-ed…
Find more information on the issues deeply affected by private equity investments:

Why Walgreens’ New CEO Should Alarm Us The man who oversaw massive store closures and job cuts at Staples is now in charge of one of America’s most important companies. The following op-ed…

Genesis Healthcare bankruptcy shows why joint liability is needed to hold private equity accountable Private equity increasingly uses bankruptcy courts to walk away from harm—not just Genesis The Genesis Healthcare bankruptcy has again prompted the Private Equity Stakeholder Project (PESP)…

As states across the country confront the growing risks of private equity ownership in hospitals, nursing homes, and physician practices, PESP’s 2025 State Healthcare Policy Review: Tracking Private Equity Oversight and Reform and…

Each month, PESP’s Healthcare Team will be putting together a roundup that shares the latest news stories related to private equity in healthcare and highlights the work that our team has published in the last month. In the…

In light of continued investor interest in healthcare and the risks associated with private equity ownership of healthcare companies, the Private Equity Stakeholder Project is tracking private equity-backed healthcare acquisitions. Below is a list of private equity healthcare buyouts,…

Private equity’s expansion into the clinical trial industry is accelerating and may reshape how medical studies are conducted and overseen. The growing consolidation of research sites and ethics review boards raises concerns about trial safety, the long-term…

In 2025, state legislatures across the country advanced a wave of proposals to rein in the risks of private equity in healthcare. Spurred by hospital closures, bankruptcies, and mounting evidence of financial extraction by private investors, lawmakers in…

States move to rein in private equity’s growing control of healthcare, new report finds Private Equity Stakeholder Project report tracks 2025 legislative wave targeting financial risks and ownership opacity in healthcare State lawmakers across the country advanced an unprecedented wave…

PESP Shares Concerns About Private Equity’s Role in Rising Healthcare Costs at Washington’s Health Care Cost Transparency Board On October 23, the Washington Health Care Cost Transparency Board (HCCTB) convened to examine the financial and structural pressures…

Last week, Bloomberg reported that Walgreens had cut pay for its retail employees following the drugstore’s $18.8 billion buyout by private equity firm Sycamore Partners. As Walgreens’ new owners look to cut costs, hourly workers…

Private equity has played a major role in the issue of surprise medical billing. The 2020 bipartisan No Surprises Act[1] attempted to address the issue of patients receiving high out-of-network bills after being treated at a supposedly in-network…

Each month, PESP’s Healthcare Team will be putting together a roundup that shares the latest news stories related to private equity in healthcare and highlights the work that our team has published in the last month. In the news…
